FAS and hematopoietic and lymphoid cell neoplasm: Edelfosine accumulates in the lipid rafts of a wide array of hematological cancer cells [9,27,34,52,53,54], leading to apoptosis through the reorganization of these membrane domains, especially by promoting co-clustering of lipid rafts and Fas/CD95 death receptor signaling [9,27,34,53,54].